Are you need IT Support Engineer? Free Consultant
Report ID: HC0028
Pages: 167
Base Year: 2023
Format: PDF
Historical Date: 2019-2022
MARKET SCOPE:
The global Cryotherapy market is projected to grow significantly, registering a CAGR of 9.1% during the forecast period (2024 – 2032).
Cryotherapy is a pain management procedure that employs localized freezing temperatures to eliminate an irritated nerve, abnormal skin cells, or specific areas of certain cancers (referred to as cryosurgery), such as prostate cancer and skin cancer. During cryotherapy, a probe is inserted into the tissue adjacent to the affected nerve to induce freezing. This freezing process deactivates the nerve, leading to the alleviation of painful nerve irritation. Cryotherapy is considered a relatively safe and effective approach for treating localized nerve irritation. Cryotherapy involves the application of extremely low temperatures in medical treatment or surgery. It is primarily utilized for the treatment of cancer and dermatologic diseases. The increasing prevalence of patients suffering from cancer and dermatologic conditions is anticipated to drive a surge in product launches within the global cryotherapy market.
MARKET OVERVIEW:
Driver: The rise in patients of dermatologic disorders and cancer as well as high preference of physicians for cryotherapy worldwide is driving the market growth.
The growing prevalence of dermatologic disorders and cancer is driving the demand for cryotherapy, contributing to the anticipated growth of the global cryotherapy market during the forecast period. For example, a report published on April 17, 2023, by the National Center for Biotechnology Information (NCBI) identified a global total of 4,859,267,654 new cases of skin and subcutaneous diseases in 2019, with a majority comprising fungal and bacterial skin conditions. The increasing preference among physicians for cryotherapy is expected to boost the demand for this treatment, thereby fostering the growth of the global cryotherapy market. In a related development, on April 24, 2023, IceCure Medical Ltd., the developer of the ProSense System, a minimally-invasive cryoablation technology designed to destroy tumors by freezing as an alternative to surgical tumor removal, announced its educational support for a Continuing Medical Education (CME) course on cryotherapy. This course was conducted at the 24th Annual Meeting of the American Society of Breast Surgeons (ASBrS) held in Boston, U.S.
Opportunities: Technological advancements in cryotherapy equipment are expected to pave the way for cryotherapy market growth in the upcoming years.
Cryotherapy has emerged as a crucial treatment option, primarily driven by continuous technological innovations and advancements in cryotherapy equipment. Notable progress has been witnessed across various types of equipment, including cryosurgery units and accessories. Developments in cryochambers and cryosaunas, extensively utilized for treating inflammation, rheumatoid arthritis, pain management, as well as general beauty and wellness therapies, have contributed to their enhancement. Additionally, significant advancements have been made in cryosurgical equipment, incorporating the utilization of supercooled liquid nitrogen or other cryogens for cooling, the introduction of thin and efficient probes in various sizes, and the adoption of narrow and improved cryoablation needles. For example, in September 2018, Galil Medical introduced the ICEfx cryoablation system as an upgrade to the existing Visual ICE system. This new system features an advanced needle platform with helium-free thaw capability, aimed at accelerating thaw-time while eliminating the cost associated with helium. The ICEfx cryoablation system is compact, easily mobilized, and simplifies procedures through user-friendly on-screen prompts.
COVID IMPACT:
Since the outbreak of the COVID-19 virus in December 2019, the disease has rapidly spread to over 100 countries worldwide, prompting the World Health Organization (WHO) to declare it a public health emergency on January 30, 2020. The impact of COVID-19 on the global economy has been threefold: it directly influenced the production and demand for drugs, created disruptions in distribution channels, and had financial ramifications for firms and financial markets. The implementation of nationwide lockdowns in various countries, including China, India, Saudi Arabia, the U.A.E., Egypt, and others, has resulted in challenges related to the transportation of goods. However, the COVID-19 pandemic has had a detrimental effect on the global cryotherapy market. This is attributed to a decrease in bed and operating room capacity, leading to significant delays in urgent and semi-elective surgical interventions. As per a 2021 report by the American College of Surgeons (ACSs), there was a shift in the nature of surgery and anesthesia practices during the COVID-19 pandemic, with the postponement of most elective and non-urgent cases.
SEGMENTATION ANALYSIS:
The oncology segment is anticipated to grow significantly during the forecast period.
Cryotherapy finds application in the treatment of various cancers, as well as certain precancerous or noncancerous conditions. Alongside prostate and liver tumors, cryosurgery proves effective for treating Retinoblastoma, early-stage skin cancers (both basal cell and squamous cell carcinomas), actinic keratosis (precancerous skin growths), and cervical intraepithelial neoplasia (precancerous conditions of the cervix). The oncology segment is anticipated to dominate the market share during the forecast period due to the high incidence and prevalence of cancer, coupled with the growing awareness of different cryotherapy approaches.
Minimally invasive ablative procedures have gained popularity as alternatives for cancer treatment and surgical tumor removal, driven by advancements in modern imaging. Tumor ablation modalities, including cryoablation procedures, are extensively utilized in clinical practice. Ongoing research into the impact of cryotherapy on cancer treatment is also on the rise. For example, a February 2022 research article titled ‘Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation’ highlighted advancements in cryoablation cancer therapy and the potential role of multifunctional nanocarriers in expanding cryoablation for cancer treatment.
The extensive and increasing research on the benefits of cryotherapy and combination cryoablation cancer therapies is expected to create better opportunities for the oncology segment. Insights into heightened R&D activities within the segment are predicted to drive its growth. For instance, in April 2021, IceCure Medical Ltd., a developer of next-generation cryoablation technology, received Breakthrough Device Designation from the FDA for its lead asset, ProSense. This liquid-nitrogen-based cryoablation system enables minimally-invasive treatment of cancer tumors. As a result, the oncology segment is experiencing significant growth and is expected to continue this trend over the forecast period, thereby contributing to the overall expansion of the studied market.
The hospital and specialty clinic segment is anticipated to grow significantly during the forecast period.
The end-user segment, specifically hospitals and specialty clinics, is poised to demonstrate the highest growth rate during the entire forecast period, reaching 8.1%. This heightened growth is driven by the growing demand for cryosurgery and associated products in hospitals and specialized clinics, fueled by advancements in cryotherapy technology for treating diverse diseases and disorders. The adoption of cryotherapy-based treatments is becoming increasingly prevalent in numerous hospitals and clinics. Over the forecast period, the segment dedicated to cryotherapy centers is expected to experience substantial growth. This growth is likely attributed to the expansion of cryotherapy facilities in key markets. Notably, in October 2021, CARE Innovative Options unveiled the Slynarski Knee Clinic, introducing computer-controlled cryotherapy solutions tailored for knee-related treatments. This development is indicative of the expanding landscape of cryotherapy centers, contributing to the overall lucrative growth anticipated in this segment throughout the projection period.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
North America stands as the largest regional market in revenue terms, propelled by substantial healthcare expenditure from local governments and the highly developed healthcare infrastructure in the United States (US) and Canada. Additionally, the availability of well-established cryotherapy products in this region is expected to contribute to market growth throughout the forecast period. The dominant factors influencing overall market growth in North America include robust healthcare expenditure, the presence of skilled professionals, a growing adoption of whole-body cryotherapy, an increasing inclination toward cryotherapy for cancers and skin disorders, a rising prevalence of cancer, and an upsurge in the adoption of minimally invasive surgeries. A key driver for this growth is the prevalence of cancer, as indicated by the Cancer Facts & Figures 2022 published by the American Cancer Society. The report estimates approximately 1.9 million new cancer cases to be diagnosed in the US. Notably, cancer ranks as the second most common cause of death in the US, following heart disease. The anticipated growth of the cryotherapy market in the region is further fueled by the recognized benefits of cryotherapy in cancer treatment and its application in the surgical removal of tumors. As a result, North America is poised for significant expansion in the cryotherapy market, driven by the convergence of these favorable factors.
COMPETITIVE ANALYSIS
The global Cryotherapy market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Scope of the Report
** In – depth qualitative analysis will be provided in the final report subject to market
Primary and Secondary Research
In order to understand the market in detail we conduct primary and secondary research. We collect as much information as we can from the market experts through primary research. We contact the experts from both demand and supply side and conduct interviews to understand the actual market scenario. In secondary research, we study and gather the data from various secondary sources such as company annual reports, press releases, whitepapers, paid databases, journals, and many other online sources. With the help of the primary interviews, we validate the data collected from secondary sources and get a deep understanding on the subject matter. Post this our team uses statistical tools to analyses the data to arrive at a conclusion and draft it in presentable manner.
Market Size Estimations
Understanding and presenting the data collected is a crucial task. Market sizing is a critical part of the data analysis and this task is performed by using Top-down and bottom-up approaches. In this process, we place different data points, market information and industry trends at a suitable space. This placement helps us presume the estimated & forecast values for coming few years. We use several mathematical and statistical models to estimate the market sizes of different countries and segments. Each of this is further added up to outline the total market. These approaches are individually done on regional/country and segment level.
Data Triangulation
As we arrive at the total market sizes, the market is again broken down into segments and subsegments. This process is called as data triangulation and is implementable wherever applicable. This step not only helps us conclude the overall market engineering process, but also gives an assurance on accuracy of the data generated. The data is triangulated based on studying the market trends, various growth factors, and aspects of both demand and supply side.